Clearview ULTRA FOB is a rapid, two-step immunochemical test
for the detection of fecal occult blood.
Clearly Different
Clearview's patented innovative technology provides highly
accurate detection of fecal occult blood.
- Fast: two easy steps with a positive
result in as little as 1 minute
- Easy: CLIA-waived, easy-to-use test
requires no training
- Reliable: built-in control ensures
accuracy
- Flexible: requires only one sample
and no dietary restrictions
Clearly Better
Clearview ULTRA FOB offers important benefits for you and your
patients.
- Aids in the diagnosis of gastrointestinal disorders, which may
lead to colorectal cancer if not treated
- Early diagnosis and treatment can lead to a significant
reduction in mortality from colorectal cancer
- Convenience and ease of collection may greatly improve patient
compliance
- As an immunochemical test, offers significantly higher
reimbursement than traditional guaiac-based tests
Clearview® ULTRA FOB Procedure
Shake sample collection bottle vigorously, then
remove the white cap on the vial. Place the sample end of the
dipstick into the sample collection bottle.
Read results in 5 minutes. Specimens with high
concentrations of Hb may produce positive results in as little as 1
minute. For full instructions for use, see package insert.
About Colorectal Cancer
Colorectal cancer (CRC) is the third most common cancer both in
men and women.1 In fact, over 56,000 Americans die from
CRC every year.1 More than 90% of cases of CRC occur in
people over the age of 50.1 However, when CRC is
detected early, it is 90% curable with treatment.1
Because CRC usually causes no symptoms in these early stages,
screening is often the only way to detect early-stage
CRC.1 The American Cancer Society recommends that men
and women 50 years of age and older should be screened for
CRC.2
Fecal occult blood (FOB) screening detects blood in the stool
that is associated with gastrointestinal disorders such as
diverticulitis, polyps, and Crohn's disease that may lead to CRC if
not treated. Early diagnosis of CRC through FOB testing and
subsequent treatment has been shown to significantly reduce
mortality from CRC.
References
- American Cancer Society. Colorectal Cancer Facts & Figures:
Special Edition 2005. Available at: http://www.cancer.org/. Accessed April
13, 2005.
- Smith RA, Cokkinides V, Eyre HJ. American Cancer Society
Guidelines for the Early Detection of Cancer, 2003. CA Cancer J
Clin. 2003;53:27-43.